Hypertension Clinical Trial
Official title:
The Effects of Variable Load Exercise on Muscle Function and Blood Pressure Regulation: a Randomized Controlled Trail
The primary aim of this research proposal is to examine whether this novel training program
approach is capable to tackle excessive loss in muscle mass, function and contractile
capacity with aging. Previous investigations have universally shown a dramatic loss in type
II muscle fibers, while certain countermeasures in their follow-up studies were generally
ineffective and limited to attenuate this phenomenon. Probably, they failed to meet
recruitment threshold of larger motor units and subsequently innervate type II muscle fibers.
Furthermore, previous investigations also failed to provide any data on specific blood
markers that may provide additional insight into muscle fiber loss with aging. Muscle fibers
type II play a crucial role in the human ability to produce as much as force as possible over
a limited time-frame (e.g. 100-200 ms) to counteract unexpected perturbations during stair
climbing for example and thus avoiding falls. Therefore, this data collection would be
noteworthy in particular, especially for this population due to health-related outcomes and
healthy aging process.
Since age-related decline is accelerated already after short bouts of physical inactivity,
with small recovery potential, any attempt to counteract age-related and disuse-related
decline have high clinical significance. Based on the findings, data collected may aid in
development of safety guidelines and protocols aimed at reducing health risks in this
specific population. Importantly, in case the aforementioned hypotheses are confirmed,
present findings may offer important information to the healthcare system, especially for
reducing economic burden.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | July 30, 2020 |
Est. primary completion date | March 30, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 50 Years to 75 Years |
Eligibility |
1. Inclusion criteria: Both genders will be included; - signed informed consent and doctor's permission; - Age >50 years; - BMI <30 kg/m2, - At least 30 minutes of daily moderate-to-vigorous physical activity during (including five days of monitoring prior to any data collection). 2. Exclusion criteria: - Severe cardiovascular diseases; - hypertension prevalence (>140/90 mm Hg). - history of severe musculoskeletal and neurological disorders/injuries; - history of severe neurological disorders; - supplement or drug consumption that may interfere with training outcomes; - alcohol consumption and smoking; - use of walking aids; The risks and benefits will be outlined to each participant before inclusion into the study. Data collection risks include potential transient discomfort from the venipuncture blood sampling and muscle soreness originating from experimental training protocols. The participants will get valuable information on how their muscles adapt following systematic training protocols. |
Country | Name | City | State |
---|---|---|---|
Slovenia | University of Primorska | Koper | |
Slovenia | ZRS Koper | Koper |
Lead Sponsor | Collaborator |
---|---|
University Hospital of Split | Slovenian Research Agency |
Slovenia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Continuous blood pressure monitoring via photopletismograpy (via Finometer) and non-invasive hemodynamics assessment | Non-pharmacological intervention (exercise intervention); To address motor unit recruitment pattern with pre-post intervention data collection scheme. | 12-24 months | |
Primary | Non invasive surface electromyography (HD EMG, in mV) during MVC (maximal voluntary contraction, Nm), Peak oxygen uptake assessment (VO2; ml kg min-1) | Pulmonary ventilation and oxygen uptake at rest and during cycling. All data will be collected via a portable system (K5 RQ, Cosmed, Rome, Italy) | 12-24 months | |
Secondary | Endothelial function (via non invasive flow mediated dilatation technique | During exercise testing we plan to use s it is a portable ultrasound imaging | 12-24 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |